Le Lézard
Classified in: Health, Science and technology
Subject: Conference

ASHG 2019 in Houston Highlights Discoveries in Genetic Research and Progress to Improve Health, Treat Disease


Thousands of genomics and genetics researchers, professors, doctors, genetic counselors, nurses, and others from around the world will gather in Houston, Texas, October 15-19, for ASHG 2019, to share their latest research about the benefits of human genetics and genomics research, one of the fastest growing fields of modern health care development. ASHG 2019, the annual meeting of the American Society of Human Genetics (ASHG), is the world's largest source of emerging news and cutting-edge science across the rapidly expanding fields of human genetics and genomics.

Scientists from nearly 80 countries will take part in more than 3,400 scientific presentations, workshops, and collaborative events. This will be the first time that Houston has hosted ASHG's annual meeting since the organization was founded in 1948. Hosting ASHG 2019 in Houston, a major epicenter of biomedical and life sciences, offers ASHG and its members an outstanding venue to inform the general public of new scientific knowledge that is changing the way we diagnose and treat disease, understand human history, and unravel fundamental biologic mysteries. It comes at a time when Houston's position as an international leader in biomedical research is growing rapidly and will expand with the construction of a collaborative 30-acre biomedical research campus downtown.

"The remarkable research that we will see at this meeting is transforming our knowledge about the role of genetics in human health and, increasingly, our ability to improve treatments and outcomes," ASHG President Dr. Leslie G. Biesecker said. "This scientific progress will be on display in Bayou City and will demonstrate the essential role of robust funding for biomedical research to further revolutionize health care and successful treatments. ASHG 2019 is the ultimate opportunity to share new scientific discoveries with fellow scientists and the public."

This year's program features exciting sessions highlighting some of the breakthroughs in research progress:

"Perspectives on Germline Gene Editing Regulation" ? A special session engaging researchers and leaders of the National Academies-led international commission about future regulatory and ethics frameworks for hereditary genome editing.
Thursday, Oct. 17, 2:30?4:00 p.m.

"Presidential Symposium on Genetic Exceptionalism" ? What barriers have historically separated geneticists from other researchers and clinicians, and how can we break them down to ensure people everywhere realize the benefits or genetics and genomics research?
Thursday, Oct. 17, 5:30 p.m.?7 p.m.

In addition, ASHG will hold a special media availability with ASHG President Leslie Biesecker and ASHG Program Committee Chair Dr. Kiran Musunuru on Wednesday, October 16 from 10:00-10:30 a.m., exclusively for registered media. During this discussion, presenters will highlight new initiatives; findings related to basic, translational, and clinical genetics; therapeutics and drug discovery; population genetics and evolution; and more. Media can register for credentials at https://www.ashg.org/2019meeting/pages/press_registration.shtml.

The American Society of Human Genetics (ASHG), founded in 1948, is the primary professional membership organization for human genetics and genomics specialists worldwide. The Society's nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others who have a special interest in the field of human genetics. For more information, visit: www.ashg.org.


These press releases may also interest you

at 15:50
Today, during the Ubisoft Forward digital conference, Ubisoft announced that the next installment in the Assassin's Creed franchise, Assassin's Creed® Valhalla, will release worldwide November 17, 2020, on Xbox One, PlayStation®4, the Epic Games...

at 13:42
Health Vector recently partnered with a major healthcare system to garner the power of AI to support medical documentation. The new product, Health Vector Clinical Transcriptions, demonstrates how instant transcription of medical encounters helps...

at 11:10
Compare-autoinsurance.org has launched a new blog post that presents some pieces of information about pay-per-mile car insurance and its advantages. For more info and free car insurance quotes, visit...

at 08:35
Takeda Pharmaceutical Company Limited ("Takeda") (TSE: 4502/NYSE:TAK) today announced that 13 abstracts are being presented from the company's Hematology portfolio and pipeline at the International Society on Thrombosis and Haemostasis 2020 Virtual...

at 08:25
Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that following its application to The Stock Exchange of Hong Kong...

11 jui 2020
Samsung Biologics (207940.KS) has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM418, an anti-PD1 immuno-oncology candidate. STM418 received much attention from the biopharma...



News published on 4 october 2019 at 09:05 and distributed by: